Physician profile
Alex Diaz
NPI 1659759363
$4,772.91
in general payments reported to CMS, 2019-2025
38 companies · $1,818 in 2025
The $1,818 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $616 · 2023: $615 · 2024: $1,486 · 2025: $1,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,779 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,779.14 |
| Education | $138.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $961.43 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $860.60 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $384.05 | 2021-2025 | Ofev, Jascayd, Jardiance |
| Pulmonx Corporation | $263.99 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Genzyme Corporation | $253.25 | 2021-2025 | |
| Insmed, INC. | $217.01 | 2022-2024 | Arikayce |
| Amgen INC. | $211.80 | 2023-2025 | Tezspire, Krystexxa |
| Inspire Medical Systems, INC. | $198.13 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $150.73 | 2021-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $140.79 | 2024-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $138.98 | 2024-2025 | |
| Inari Medical, INC. | $104.50 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Verona Pharma, INC. | $77.30 | 2025 | Ohtuvayre |
| Baxter Healthcare | $71.18 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $70.22 | 2023-2025 | Cuvitru, Glassia |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $67.00 | 2025 | Acthar |
| Lundbeck LLC | $66.42 | 2024-2025 | Rexulti |
| Mylan Specialty L.P. | $65.50 | 2021-2024 | Yupelri |
| Philips North America LLC | $47.79 | 2023-2025 | Vest Therapy Und |
| Stryker Corporation | $40.35 | 2025 | Flowtriever |
| Alexion Pharmaceuticals, INC. | $33.70 | 2025 | Ultomiris |
| Exact Sciences Corporation | $30.84 | 2024 | Cologuard Collection Kit |
| Abiomed | $29.30 | 2024 | Impella |
| Abbvie INC. | $27.03 | 2022 | |
| Nestle Healthcare Nutrition INC. | $25.31 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $24.45 | 2022 | |
| La Jolla Pharmaceutical Company | $22.96 | 2024 | Giapreza |
| Edwards Lifesciences Corporation | $22.21 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Vivus LLC | $21.97 | 2022 | |
| Ethicon INC. | $20.38 | 2022 | |
| Biogen, INC. | $19.28 | 2024 | Spinraza |
| Neurocrine Biosciences, INC. | $17.02 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.31 | 2023 | Rexulti |
| Sumitomo Pharma America, INC. | $15.81 | 2024 | Gemtesa |
| Actelion Pharmaceuticals US, INC. | $14.35 | 2023 | Opsumit, Uptravi |
| Avanir Pharmaceuticals, INC. | $13.84 | 2021 | |
| Gilead Sciences, INC. | $13.69 | 2023 | Veklury |
| Pfizer INC. | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.